144 related articles for article (PubMed ID: 8655680)
1. Neuroendocrine differentiation in cervical carcinoma.
Savargaonkar PR; Hale RJ; Mutton A; Manning V; Buckley CH
J Clin Pathol; 1996 Feb; 49(2):139-41. PubMed ID: 8655680
[TBL] [Abstract][Full Text] [Related]
2. Histologic and immunophenotypic classification of cervical carcinomas by expression of the p53 homologue p63: a study of 250 cases.
Wang TY; Chen BF; Yang YC; Chen H; Wang Y; Cviko A; Quade BJ; Sun D; Yang A; McKeon FD; Crum CP
Hum Pathol; 2001 May; 32(5):479-86. PubMed ID: 11381365
[TBL] [Abstract][Full Text] [Related]
3. Biological and clinical significance of NAC1 expression in cervical carcinomas: a comparative study between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas.
Yeasmin S; Nakayama K; Rahman MT; Rahman M; Ishikawa M; Katagiri A; Iida K; Nakayama N; Otuski Y; Kobayashi H; Nakayama S; Miyazaki K
Hum Pathol; 2012 Apr; 43(4):506-19. PubMed ID: 21889186
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine marker expression in cervical carcinomas of non-small cell type.
Chavez-Blanco A; Taja-Chayeb L; Cetina L; Chanona-Vilchis G; Trejo-Becerril C; Perez-Cardenas E; Segura-Pacheco B; Acuña-González C; Dueñas-Gonzalez A
Int J Gynecol Pathol; 2002 Oct; 21(4):368-74. PubMed ID: 12352185
[TBL] [Abstract][Full Text] [Related]
5. Hep Par 1 expression in carcinoma of the cervix: implications for diagnosis and prognosis.
Thamboo TP; Wee A
J Clin Pathol; 2004 Jan; 57(1):48-53. PubMed ID: 14693835
[TBL] [Abstract][Full Text] [Related]
6. Spectrum of neuroendocrine carcinomas of the uterine cervix, including histopathologic features, terminology, immunohistochemical profile, and clinical outcomes in a series of 50 cases from a single institution in India.
Rekhi B; Patil B; Deodhar KK; Maheshwari A; A Kerkar R; Gupta S; Tongaonkar HB; Shrivastava SK
Ann Diagn Pathol; 2013 Feb; 17(1):1-9. PubMed ID: 22534245
[TBL] [Abstract][Full Text] [Related]
7. Cervical Carcinomas With Neuroendocrine Differentiation: A Report of 28 Cases With Immunohistochemical Analysis and Molecular Genetic Evidence of Common Clonal Origin With Coexisting Squamous and Adenocarcinomas.
Emerson RE; Michael H; Wang M; Zhang S; Roth LM; Cheng L
Int J Gynecol Pathol; 2016 Jul; 35(4):372-84. PubMed ID: 26630233
[TBL] [Abstract][Full Text] [Related]
8. RETRACTED ARTICLE: Cervical adenosquamous carcinoma: detailed analysis of morphology, immunohistochemical profile, and clinical outcomes in 59 cases.
Stolnicu S; Hoang L; Hanko-Bauer O; Barsan I; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Oliva E; Park KJ; Soslow RA
Mod Pathol; 2019 Feb; 32(2):269-279. PubMed ID: 30258209
[TBL] [Abstract][Full Text] [Related]
9. A study of the value and prognostic significance of mucin staining in squamous cell carcinoma of the uterine cervix.
Langlois NE; Ellul B; Miller ID
Histopathology; 1996 Feb; 28(2):175-8. PubMed ID: 8834528
[TBL] [Abstract][Full Text] [Related]
10. The pathology of cervical tumours.
Tiltman AJ
Best Pract Res Clin Obstet Gynaecol; 2005 Aug; 19(4):485-500. PubMed ID: 16150389
[TBL] [Abstract][Full Text] [Related]
11. Cd44: a marker of squamous differentiation in adenosquamous neoplasms.
Ylagan LR; Scholes J; Demopoulos R
Arch Pathol Lab Med; 2000 Feb; 124(2):212-5. PubMed ID: 10656728
[TBL] [Abstract][Full Text] [Related]
12. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.
McCluggage WG; Kennedy K; Busam KJ
Am J Surg Pathol; 2010 Apr; 34(4):525-32. PubMed ID: 20182342
[TBL] [Abstract][Full Text] [Related]
13. DeltaNp63 protein expression in uterine cervical and endometrial cancers.
Lin Z; Liu M; Li Z; Kim C; Lee E; Kim I
J Cancer Res Clin Oncol; 2006 Dec; 132(12):811-6. PubMed ID: 16804722
[TBL] [Abstract][Full Text] [Related]
14. Re-classification of carcinoma cervix uteri by mucin histochemistry.
Misra V; Gupta SC; Goel A; Singh PA
Indian J Pathol Microbiol; 1997 Oct; 40(4):463-8. PubMed ID: 9444856
[TBL] [Abstract][Full Text] [Related]
15. Bcl2 expression and its correlation with neuroendocrine differentiation in colon carcinomas.
Atasoy P; Bozdoğan O; Oztürk S; Ensari A
Tumori; 2004; 90(2):233-8. PubMed ID: 15237588
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine differentiation in gastric adenocarcinomas; correlation with tumor stage and expression of VEGF and p53.
Eren F; Celikel C; Güllüoğlu B
Pathol Oncol Res; 2004; 10(1):47-51. PubMed ID: 15029262
[TBL] [Abstract][Full Text] [Related]
17. Cervical Adenosquamous Carcinoma: Detailed Analysis of Morphology, Immunohistochemical Profile, and Outcome in 59 Cases.
Stolnicu S; Hoang L; Zhou Q; Iasonos A; Terinte C; Pesci A; Aviel-Ronen S; Kiyokawa T; Alvarado-Cabrero I; Oliva E; Park KJ; Soslow RA
Int J Gynecol Pathol; 2023 May; 42(3):259-269. PubMed ID: 36044310
[TBL] [Abstract][Full Text] [Related]
18. The prognosis of adenosquamous carcinomas of the uterine cervix.
Bethwaite P; Yeong ML; Holloway L; Robson B; Duncan G; Lamb D
Br J Obstet Gynaecol; 1992 Sep; 99(9):745-50. PubMed ID: 1420015
[TBL] [Abstract][Full Text] [Related]
19. Frequent presence of neuroendocrine small cells in thymic carcinoma: a light microscopic and immunohistochemical study.
Kuo TT
Histopathology; 2000 Jul; 37(1):19-26. PubMed ID: 10931214
[TBL] [Abstract][Full Text] [Related]
20. Gastric-type cervical adenocarcinoma with squamous differentiation: buried in adenosquamous carcinomas?
Yoshida H; Naka T; Kobayashi-Kato M; Kikkawa N; Tanase Y; Uno M; Ishikawa M; Kato T
Virchows Arch; 2021 Aug; 479(2):407-412. PubMed ID: 33404855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
